Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Biodel awarded NIH grant to develop concentrated ultrarapid-acting insulin

July 27, 2012

New protein kinase inhibitors synthesized at Sanofi

July 26, 2012

European Commission approves combination tablet for type 2 diabetes

July 25, 2012

BioCryst reports on two phase II trials of BCX-4208

July 25, 2012

Candidate Syntaxin drug for acromegaly has new mode of action

July 25, 2012

Enrollment complete in pivotal CompleoTRT trial

July 24, 2012

Repros provides update on phase II uterine fibroid trial

July 24, 2012

EMA committee recommends approval of first gene therapy

July 23, 2012

Sanofi and Regeneron launch phase III program for LDL-lowering antibody

July 20, 2012

University of Alberta kicks off phase I/II study of pan-caspase inhibitor

July 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...